| 常用名 | Cetrelimab | CAS号 | 2050478-92-5 |
|---|---|---|---|
| 价格 | 纯度 | 95.0% | |
| 备货期 | 10天 | 库存 | 现货 |
| 产品详情(用途,包装等)
用途: Cetrelimab (JNJ 63723283; JNJ 3283) is a humanized IgG4κ mAb targeting PD-1. Cetrelimab binds PD-1 (Kd=1.72 nM, HEK293) to block the interaction of PD-1 with PD-L1 and PD-L2 (IC50s=111.7 ng/mL and 138.6 ng/mL, respectively). Cetrelimab stimulates peripheral T cells, increases IFN-γ, IL-2, TNF-α level and inhibits tumor growth in vivo[1]. 物理化学性质: CAS号:2050478-92-5 常用中文名:Cetrelimab 常用英文名:Cetrelimab 分子式: 分子量: 密度:N/A 沸点:N/A 熔点:N/A 闪点:N/A |